Journal of Clinical Investigation · 1983 · 173 citations · 14 references
MedicineBiochemistryCell BiologyCell SignalingHormone BiochemistrySignal TransductionKidney CancerParathyroid Gland PhysiologyParathyroid Hormone PhysiologyParathyroid Hormone RegulationParathyroid NeoplasmsRenal Cell CarcinomaAdenylate Cyclase RegulationAdenylate Cyclase SignalingHypercalcemia Of MalignancyParathyroid Cell FunctionParathyroid Hormone BiologyParathyroid PathologyTumor-induced Hypercalcemia
When grown in nude mice, cultured renal carcinoma cells from a hypercalcemic patient produced marked hypercalcemia that was reversed by resection of tumor. Conditioned medium from this cell line contained a protein with activity in a renal adenylate cyclase bioassay for parathyroid hormone (PTH) which was blocked by the competitive PTH antagonist [8norleucyl, 18norleucyl, 34tyrosinyl]bPTH (3-34)amide. However, the biologically active protein was eluted from gel filtration columns as a larger molecular size component that PTH and was not recognized by any of four region-specific PTH antisera. The properties of this factor resemble those of the postulated PTH-like substance(s) in humoral hypercalcemia of malignancy.
14
Biochemical Evaluation of Patients with Cancer-Associated Hypercalcemia
Andrew F. Stewart, Ronald L. Horst, Leonard J. Deftos et al. · New England Journal of Medicine · 1980 · 720 citations
Medicine, Endocrinology, Oncology +17
G V Segre, Michael Rosenblatt, B. Reiner et al. · Journal of Biological Chemistry · 1979 · 166 citations · Full text